Yes, they will likely need to do 5 or 10 year safety studies with very large data sets because of the MOA of the cancer inducing mechanism of iPSCs. That will be very, very expensive. FDA will give them no leeway as none of their indications are for unmet needs.
Yes, they will likely need to do 5 or 10 year safety studies...
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
-0.035(3.41%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 96.5¢ | $8.837M | 8.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59782 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 26617 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |